Rank | Gene Set | Z-score |
---|---|---|
1 | detection of molecule of bacterial origin (GO:0032490) | 6.11832877 |
2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.74712211 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.35418874 |
4 | low-density lipoprotein particle clearance (GO:0034383) | 5.02561950 |
5 | neutrophil activation involved in immune response (GO:0002283) | 4.97229054 |
6 | detection of other organism (GO:0098543) | 4.90066392 |
7 | cellular extravasation (GO:0045123) | 4.88250099 |
8 | detection of external biotic stimulus (GO:0098581) | 4.73520525 |
9 | negative regulation of cell killing (GO:0031342) | 4.70580668 |
10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.70580668 |
11 | response to peptidoglycan (GO:0032494) | 4.42157879 |
12 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.37066511 |
13 | macrophage activation (GO:0042116) | 4.26629008 |
14 | regulation of cholesterol storage (GO:0010885) | 4.22928753 |
15 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.16506303 |
16 | negative regulation of interleukin-12 production (GO:0032695) | 4.12914291 |
17 | detection of biotic stimulus (GO:0009595) | 4.10711510 |
18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05257645 |
19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04273408 |
20 | detection of bacterium (GO:0016045) | 4.02390727 |
21 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.01233589 |
22 | * regulation of sequestering of triglyceride (GO:0010889) | 3.95677953 |
23 | neutrophil mediated immunity (GO:0002446) | 3.78423965 |
24 | negative regulation of granulocyte differentiation (GO:0030853) | 3.77570240 |
25 | respiratory burst (GO:0045730) | 3.69504708 |
26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.66753932 |
27 | response to host immune response (GO:0052572) | 3.64673935 |
28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.64673935 |
29 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.62260928 |
30 | white fat cell differentiation (GO:0050872) | 3.55975301 |
31 | regulation of mast cell degranulation (GO:0043304) | 3.55624654 |
32 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.55152255 |
33 | fatty acid transmembrane transport (GO:1902001) | 3.51705117 |
34 | neutrophil activation (GO:0042119) | 3.50770562 |
35 | myeloid cell activation involved in immune response (GO:0002275) | 3.46414088 |
36 | myeloid leukocyte mediated immunity (GO:0002444) | 3.44419354 |
37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43305781 |
38 | apoptotic cell clearance (GO:0043277) | 3.43059954 |
39 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.39693159 |
40 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.38628355 |
41 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.38490437 |
42 | regulation of mast cell activation (GO:0033003) | 3.38374379 |
43 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.36945064 |
44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.35992876 |
45 | positive regulation of macrophage cytokine production (GO:0060907) | 3.35891896 |
46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35287223 |
47 | positive regulation of mast cell activation (GO:0033005) | 3.29912936 |
48 | I-kappaB phosphorylation (GO:0007252) | 3.28340995 |
49 | fibroblast migration (GO:0010761) | 3.27045561 |
50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.25100139 |
51 | growth hormone receptor signaling pathway (GO:0060396) | 3.24836607 |
52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23864386 |
53 | response to host (GO:0075136) | 3.23864386 |
54 | response to host defenses (GO:0052200) | 3.23864386 |
55 | granulocyte activation (GO:0036230) | 3.17667686 |
56 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.17323516 |
57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.15462815 |
58 | regulation of leukocyte degranulation (GO:0043300) | 3.15242043 |
59 | carnitine shuttle (GO:0006853) | 3.14389156 |
60 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.11150938 |
61 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.08612148 |
62 | nuclear pore complex assembly (GO:0051292) | 3.08562575 |
63 | immunoglobulin mediated immune response (GO:0016064) | 3.05760466 |
64 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.05656001 |
65 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.05470642 |
66 | leukocyte aggregation (GO:0070486) | 3.03744628 |
67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01604820 |
68 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01604820 |
69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01604820 |
70 | modulation by symbiont of host immune response (GO:0052553) | 3.01604820 |
71 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01604820 |
72 | modulation by symbiont of host defense response (GO:0052031) | 3.01604820 |
73 | actin-myosin filament sliding (GO:0033275) | 3.01589451 |
74 | muscle filament sliding (GO:0030049) | 3.01589451 |
75 | biotin metabolic process (GO:0006768) | 3.00504679 |
76 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.99282172 |
77 | regulation of mitotic spindle organization (GO:0060236) | 2.99149296 |
78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98341571 |
79 | brown fat cell differentiation (GO:0050873) | 2.97466372 |
80 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.95942775 |
81 | regulation of macrophage cytokine production (GO:0010935) | 2.95645264 |
82 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.95561851 |
83 | dendritic cell migration (GO:0036336) | 2.95189961 |
84 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.94116749 |
85 | iron ion import (GO:0097286) | 2.92748235 |
86 | positive regulation of fatty acid oxidation (GO:0046321) | 2.92645189 |
87 | B cell receptor signaling pathway (GO:0050853) | 2.92462426 |
88 | regulation of macrophage chemotaxis (GO:0010758) | 2.91727368 |
89 | mitotic chromosome condensation (GO:0007076) | 2.86674956 |
90 | negative regulation of lipid storage (GO:0010888) | 2.86223991 |
91 | skeletal muscle contraction (GO:0003009) | 2.84978161 |
92 | cellular response to ethanol (GO:0071361) | 2.84589208 |
93 | regulation of tolerance induction (GO:0002643) | 2.84154638 |
94 | negative regulation of macrophage differentiation (GO:0045650) | 2.83432212 |
95 | regulation of spindle organization (GO:0090224) | 2.82952227 |
96 | negative regulation of interleukin-17 production (GO:0032700) | 2.82489424 |
97 | intracellular lipid transport (GO:0032365) | 2.82159666 |
98 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.81854825 |
99 | microglial cell activation (GO:0001774) | 2.81225297 |
100 | valine metabolic process (GO:0006573) | 2.80854614 |
101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80356209 |
102 | regulation of tight junction assembly (GO:2000810) | 2.80280495 |
103 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79829654 |
104 | positive regulation of mast cell degranulation (GO:0043306) | 2.79534274 |
105 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.79534274 |
106 | regulation of T cell tolerance induction (GO:0002664) | 2.78572989 |
107 | neutrophil chemotaxis (GO:0030593) | 2.78546018 |
108 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.78269697 |
109 | cellular response to growth hormone stimulus (GO:0071378) | 2.77208406 |
110 | nuclear pore organization (GO:0006999) | 2.74424094 |
111 | regulation of cellular amide metabolic process (GO:0034248) | 2.74350679 |
112 | cellular polysaccharide catabolic process (GO:0044247) | 2.73349322 |
113 | triglyceride catabolic process (GO:0019433) | 2.72073165 |
114 | regulation of beta-amyloid formation (GO:1902003) | 2.71391116 |
115 | oligosaccharide catabolic process (GO:0009313) | 2.71277083 |
116 | neutrophil migration (GO:1990266) | 2.70488431 |
117 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.68219632 |
118 | actin-mediated cell contraction (GO:0070252) | 2.67382657 |
119 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.67376055 |
120 | lipid storage (GO:0019915) | 2.67222385 |
121 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.65331840 |
122 | glucan catabolic process (GO:0009251) | 2.64208325 |
123 | negative regulation of B cell mediated immunity (GO:0002713) | 2.63350090 |
124 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.63350090 |
125 | B cell mediated immunity (GO:0019724) | 2.62944856 |
126 | pentose-phosphate shunt (GO:0006098) | 2.62112041 |
127 | regulation of sister chromatid cohesion (GO:0007063) | 2.61923154 |
128 | response to interleukin-15 (GO:0070672) | 2.60417220 |
129 | polysaccharide catabolic process (GO:0000272) | 2.60337377 |
130 | negative regulation of exocytosis (GO:0045920) | 2.59459936 |
131 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.58908519 |
132 | peptidyl-threonine phosphorylation (GO:0018107) | 2.58748197 |
133 | positive regulation of B cell differentiation (GO:0045579) | 2.58485454 |
134 | regulation of RNA export from nucleus (GO:0046831) | 2.58358590 |
135 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58149123 |
136 | positive regulation of leukocyte degranulation (GO:0043302) | 2.57731996 |
137 | regulation of interferon-alpha production (GO:0032647) | 2.57248740 |
138 | NADPH regeneration (GO:0006740) | 2.56278638 |
139 | macrophage activation involved in immune response (GO:0002281) | 2.55735482 |
140 | mitotic metaphase plate congression (GO:0007080) | 2.55279573 |
141 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.54957101 |
142 | plasma lipoprotein particle clearance (GO:0034381) | 2.53079083 |
143 | positive regulation of cholesterol efflux (GO:0010875) | 2.51443356 |
144 | protein localization to kinetochore (GO:0034501) | 2.50671534 |
145 | positive regulation of histone deacetylation (GO:0031065) | 2.50554602 |
146 | protein localization to chromosome, centromeric region (GO:0071459) | 2.50325799 |
147 | response to laminar fluid shear stress (GO:0034616) | 2.49753071 |
148 | pore complex assembly (GO:0046931) | 2.49302534 |
149 | histone H3-K9 demethylation (GO:0033169) | 2.48274878 |
150 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.47212990 |
151 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.47212990 |
152 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.47212990 |
153 | * positive regulation of lipid storage (GO:0010884) | 2.46266647 |
154 | regulation of fatty acid oxidation (GO:0046320) | 2.45911780 |
155 | NLS-bearing protein import into nucleus (GO:0006607) | 2.44556768 |
156 | positive regulation of cholesterol transport (GO:0032376) | 2.41496128 |
157 | positive regulation of sterol transport (GO:0032373) | 2.41496128 |
158 | histone H2A monoubiquitination (GO:0035518) | 2.40012121 |
159 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.39833111 |
160 | alpha-linolenic acid metabolic process (GO:0036109) | 2.38578691 |
161 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.38249965 |
162 | regulation of hippo signaling (GO:0035330) | 2.38186711 |
163 | neutral lipid catabolic process (GO:0046461) | 2.37164181 |
164 | acylglycerol catabolic process (GO:0046464) | 2.37164181 |
165 | mitotic sister chromatid cohesion (GO:0007064) | 2.35872912 |
166 | carnitine transmembrane transport (GO:1902603) | 2.35418721 |
167 | positive regulation of chromosome segregation (GO:0051984) | 2.34686064 |
168 | positive regulation of lipid catabolic process (GO:0050996) | 2.33129520 |
169 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.30116470 |
170 | complement activation, alternative pathway (GO:0006957) | 2.30079698 |
171 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.29706352 |
172 | basement membrane organization (GO:0071711) | 2.28605203 |
173 | ovulation from ovarian follicle (GO:0001542) | 2.27970087 |
174 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.27907182 |
175 | phospholipid homeostasis (GO:0055091) | 2.27489077 |
176 | response to UV-C (GO:0010225) | 2.27457139 |
177 | regulation of mononuclear cell migration (GO:0071675) | 2.27251910 |
178 | female genitalia development (GO:0030540) | 2.25263205 |
179 | germ cell migration (GO:0008354) | 2.24365059 |
180 | fatty acid beta-oxidation (GO:0006635) | 2.24138480 |
181 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.24089012 |
182 | histone H3-K36 demethylation (GO:0070544) | 2.23419426 |
183 | mitotic nuclear envelope disassembly (GO:0007077) | 2.22072202 |
184 | positive regulation of interferon-alpha production (GO:0032727) | 2.21799441 |
185 | lipoprotein transport (GO:0042953) | 2.21479430 |
186 | amino-acid betaine transport (GO:0015838) | 2.20671093 |
187 | carnitine transport (GO:0015879) | 2.20671093 |
188 | vagina development (GO:0060068) | 2.18932927 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.32410803 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.01264008 |
3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.41776779 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.09048381 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.53239847 |
6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.31020181 |
7 | * CLOCK_20551151_ChIP-Seq_293T_Human | 3.06290434 |
8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.86857959 |
9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.84686975 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59034541 |
11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.52994960 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.29060986 |
13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10535723 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05555648 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00376694 |
16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98845586 |
17 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.98836099 |
18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98663620 |
19 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98120551 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93666931 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.93469413 |
22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90414852 |
23 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.89325859 |
24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82672323 |
25 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76379345 |
26 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.76176556 |
27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.75800657 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72927677 |
29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.71780869 |
30 | MYC_22102868_ChIP-Seq_BL_Human | 1.70027038 |
31 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.65772380 |
32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64857501 |
33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.64793802 |
34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63332514 |
35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.62570833 |
36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59567417 |
37 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57335631 |
38 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56876033 |
39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54550087 |
40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53944085 |
41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.52634560 |
42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52191386 |
43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49243946 |
44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47281383 |
45 | MYB_26560356_Chip-Seq_TH2_Human | 1.47033880 |
46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.45478005 |
47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.42369583 |
48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41942100 |
49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40485364 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39044309 |
51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38764461 |
52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38447748 |
53 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.38304394 |
54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38299693 |
55 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.37753182 |
56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36588152 |
57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36275416 |
58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34296306 |
59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33699903 |
60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31988367 |
61 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31324231 |
62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29754156 |
63 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29069711 |
64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27997626 |
65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27348972 |
66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26841217 |
67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.26627632 |
68 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26301956 |
69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26148721 |
70 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.26103695 |
71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24740157 |
72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24026885 |
73 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23843399 |
74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23699536 |
75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23252722 |
76 | MAF_26560356_Chip-Seq_TH1_Human | 1.19492070 |
77 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17954501 |
78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16292310 |
79 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16159206 |
80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16156977 |
81 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.15277293 |
82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15153401 |
83 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.14710775 |
84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14519127 |
85 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13921558 |
86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13703997 |
87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12812330 |
88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12673764 |
89 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12369574 |
90 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11767167 |
91 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.11725754 |
92 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.11258190 |
93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10876475 |
94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10407191 |
95 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.10311210 |
96 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.10311210 |
97 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.10311210 |
98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09824208 |
99 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09494720 |
100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08196503 |
101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08196503 |
102 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07112998 |
103 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06459559 |
104 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.06374116 |
105 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05373393 |
106 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.05057416 |
107 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04914515 |
108 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04757921 |
109 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.04659201 |
110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04454914 |
111 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04389767 |
112 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03925373 |
113 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03678088 |
114 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02858129 |
115 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02419825 |
116 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.02136822 |
117 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01627983 |
118 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01208216 |
119 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99142617 |
120 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98968438 |
121 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98859914 |
122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98761546 |
123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98566736 |
124 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98022020 |
125 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98010944 |
126 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97990845 |
127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97660518 |
128 | MYB_26560356_Chip-Seq_TH1_Human | 0.97562553 |
129 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96175235 |
130 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95775342 |
131 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95520568 |
132 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95441650 |
133 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95043718 |
134 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94607626 |
135 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93920889 |
136 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.93570367 |
137 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93349965 |
138 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.92665830 |
139 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92629688 |
140 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91890625 |
141 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91728134 |
142 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91423724 |
143 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91423724 |
144 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91177059 |
145 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90969238 |
146 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90521636 |
147 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90416196 |
148 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90044408 |
149 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.89780410 |
150 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89583205 |
151 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.89326048 |
152 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89174664 |
153 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87424538 |
154 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85632697 |
155 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85124043 |
156 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.84879735 |
157 | P300_19829295_ChIP-Seq_ESCs_Human | 0.84790447 |
158 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84187366 |
159 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.83692276 |
160 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80577180 |
161 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.79740518 |
162 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.78869981 |
163 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77881883 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 4.52292904 |
2 | MP0003646_muscle_fatigue | 4.50950490 |
3 | MP0003724_increased_susceptibility_to | 3.89449900 |
4 | MP0004185_abnormal_adipocyte_glucose | 3.26790502 |
5 | MP0008438_abnormal_cutaneous_collagen | 3.25005629 |
6 | MP0003705_abnormal_hypodermis_morpholog | 3.15401713 |
7 | MP0005666_abnormal_adipose_tissue | 3.05588293 |
8 | MP0008057_abnormal_DNA_replication | 2.80404860 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.42348037 |
10 | MP0008260_abnormal_autophagy | 2.40310437 |
11 | MP0004130_abnormal_muscle_cell | 2.35776671 |
12 | MP0000749_muscle_degeneration | 2.30533085 |
13 | MP0000569_abnormal_digit_pigmentation | 2.17045800 |
14 | MP0009840_abnormal_foam_cell | 2.16940267 |
15 | MP0002332_abnormal_exercise_endurance | 2.11065648 |
16 | MP0004233_abnormal_muscle_weight | 2.09618192 |
17 | MP0003011_delayed_dark_adaptation | 2.09198025 |
18 | MP0005375_adipose_tissue_phenotype | 2.04761900 |
19 | MP0003656_abnormal_erythrocyte_physiolo | 1.98551291 |
20 | MP0005076_abnormal_cell_differentiation | 1.94201536 |
21 | MP0005058_abnormal_lysosome_morphology | 1.87628589 |
22 | MP0004036_abnormal_muscle_relaxation | 1.86078467 |
23 | MP0009785_altered_susceptibility_to | 1.74549193 |
24 | MP0001800_abnormal_humoral_immune | 1.72854212 |
25 | MP0004883_abnormal_blood_vessel | 1.71727203 |
26 | MP0003566_abnormal_cell_adhesion | 1.62462526 |
27 | MP0003303_peritoneal_inflammation | 1.62092432 |
28 | MP0009115_abnormal_fat_cell | 1.61769395 |
29 | MP0005000_abnormal_immune_tolerance | 1.59851184 |
30 | MP0002971_abnormal_brown_adipose | 1.58815384 |
31 | MP0001790_abnormal_immune_system | 1.58407331 |
32 | MP0005387_immune_system_phenotype | 1.58407331 |
33 | MP0000685_abnormal_immune_system | 1.57817570 |
34 | MP0010307_abnormal_tumor_latency | 1.56708094 |
35 | MP0002723_abnormal_immune_serum | 1.55368528 |
36 | MP0005025_abnormal_response_to | 1.52668820 |
37 | MP0010352_gastrointestinal_tract_polyps | 1.49710948 |
38 | MP0010329_abnormal_lipoprotein_level | 1.49311089 |
39 | MP0002420_abnormal_adaptive_immunity | 1.47871701 |
40 | MP0005671_abnormal_response_to | 1.45996824 |
41 | MP0001819_abnormal_immune_cell | 1.45656060 |
42 | MP0005310_abnormal_salivary_gland | 1.40880395 |
43 | MP0005275_abnormal_skin_tensile | 1.39990634 |
44 | MP0005360_urolithiasis | 1.38279624 |
45 | MP0005451_abnormal_body_composition | 1.33496187 |
46 | MP0003828_pulmonary_edema | 1.32219724 |
47 | MP0000747_muscle_weakness | 1.31575598 |
48 | MP0010234_abnormal_vibrissa_follicle | 1.31336938 |
49 | MP0002405_respiratory_system_inflammati | 1.31118538 |
50 | MP0000609_abnormal_liver_physiology | 1.30818721 |
51 | MP0002269_muscular_atrophy | 1.30225026 |
52 | MP0005083_abnormal_biliary_tract | 1.29341872 |
53 | MP0001915_intracranial_hemorrhage | 1.27340183 |
54 | MP0004484_altered_response_of | 1.27163468 |
55 | MP0006082_CNS_inflammation | 1.25797817 |
56 | MP0004145_abnormal_muscle_electrophysio | 1.24961251 |
57 | MP0005164_abnormal_response_to | 1.20417429 |
58 | MP0001661_extended_life_span | 1.19890009 |
59 | MP0003111_abnormal_nucleus_morphology | 1.19847281 |
60 | MP0002009_preneoplasia | 1.19468994 |
61 | MP0009278_abnormal_bone_marrow | 1.19415136 |
62 | MP0002148_abnormal_hypersensitivity_rea | 1.19181123 |
63 | MP0005620_abnormal_muscle_contractility | 1.19037855 |
64 | MP0008007_abnormal_cellular_replicative | 1.18825825 |
65 | MP0003091_abnormal_cell_migration | 1.18773908 |
66 | MP0000733_abnormal_muscle_development | 1.18517417 |
67 | MP0005464_abnormal_platelet_physiology | 1.18334399 |
68 | MP0003279_aneurysm | 1.18331118 |
69 | MP0003077_abnormal_cell_cycle | 1.15987283 |
70 | MP0002396_abnormal_hematopoietic_system | 1.15595107 |
71 | MP0000767_abnormal_smooth_muscle | 1.15420459 |
72 | MP0002106_abnormal_muscle_physiology | 1.15200682 |
73 | MP0002166_altered_tumor_susceptibility | 1.15136769 |
74 | MP0000003_abnormal_adipose_tissue | 1.13191649 |
75 | MP0002088_abnormal_embryonic_growth/wei | 1.12843136 |
76 | MP0003436_decreased_susceptibility_to | 1.12609398 |
77 | MP0005330_cardiomyopathy | 1.11904573 |
78 | MP0001849_ear_inflammation | 1.11455950 |
79 | MP0003984_embryonic_growth_retardation | 1.11281333 |
80 | MP0005023_abnormal_wound_healing | 1.10740274 |
81 | MP0003448_altered_tumor_morphology | 1.10714710 |
82 | MP0003183_abnormal_peptide_metabolism | 1.10271152 |
83 | MP0000716_abnormal_immune_system | 1.09991169 |
84 | MP0003950_abnormal_plasma_membrane | 1.09845292 |
85 | MP0001672_abnormal_embryogenesis/_devel | 1.09721470 |
86 | MP0005380_embryogenesis_phenotype | 1.09721470 |
87 | MP0002972_abnormal_cardiac_muscle | 1.08455715 |
88 | MP0003300_gastrointestinal_ulcer | 1.07776900 |
89 | MP0002277_abnormal_respiratory_mucosa | 1.07338100 |
90 | MP0002398_abnormal_bone_marrow | 1.06942784 |
91 | MP0005365_abnormal_bile_salt | 1.05685351 |
92 | MP0002127_abnormal_cardiovascular_syste | 1.05042697 |
93 | MP0003045_fibrosis | 1.04582920 |
94 | MP0005334_abnormal_fat_pad | 1.04483556 |
95 | MP0002970_abnormal_white_adipose | 1.04367915 |
96 | MP0000751_myopathy | 1.03889006 |
97 | MP0001730_embryonic_growth_arrest | 1.03434361 |
98 | MP0005376_homeostasis/metabolism_phenot | 1.02836473 |
99 | MP0000689_abnormal_spleen_morphology | 1.02543400 |
100 | MP0008961_abnormal_basal_metabolism | 1.01250812 |
101 | MP0008877_abnormal_DNA_methylation | 1.00021392 |
102 | MP0009053_abnormal_anal_canal | 0.98899578 |
103 | MP0002006_tumorigenesis | 0.98361317 |
104 | MP0001845_abnormal_inflammatory_respons | 0.97492260 |
105 | MP0002697_abnormal_eye_size | 0.96939742 |
106 | MP0004272_abnormal_basement_membrane | 0.96806105 |
107 | MP0010368_abnormal_lymphatic_system | 0.96559497 |
108 | MP0002133_abnormal_respiratory_system | 0.96041522 |
109 | MP0005388_respiratory_system_phenotype | 0.96041522 |
110 | MP0003690_abnormal_glial_cell | 0.95401364 |
111 | MP0006138_congestive_heart_failure | 0.95201757 |
112 | MP0002086_abnormal_extraembryonic_tissu | 0.92606590 |
113 | MP0001727_abnormal_embryo_implantation | 0.92182011 |
114 | MP0002638_abnormal_pupillary_reflex | 0.91927356 |
115 | MP0002722_abnormal_immune_system | 0.91745811 |
116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91589011 |
117 | MP0000759_abnormal_skeletal_muscle | 0.90785740 |
118 | MP0003075_altered_response_to | 0.90333300 |
119 | MP0003693_abnormal_embryo_hatching | 0.89888371 |
120 | MP0004381_abnormal_hair_follicle | 0.89541820 |
121 | MP0005397_hematopoietic_system_phenotyp | 0.89527691 |
122 | MP0001545_abnormal_hematopoietic_system | 0.89527691 |
123 | MP0000858_altered_metastatic_potential | 0.88411842 |
124 | MP0000343_altered_response_to | 0.88274518 |
125 | MP0005085_abnormal_gallbladder_physiolo | 0.86851617 |
126 | MP0001835_abnormal_antigen_presentation | 0.86540434 |
127 | MP0001533_abnormal_skeleton_physiology | 0.86390779 |
128 | MP0006054_spinal_hemorrhage | 0.83997165 |
129 | MP0005174_abnormal_tail_pigmentation | 0.82184827 |
130 | MP0001853_heart_inflammation | 0.81946395 |
131 | MP0008469_abnormal_protein_level | 0.81569992 |
132 | MP0001958_emphysema | 0.81444025 |
133 | MP0000465_gastrointestinal_hemorrhage | 0.80721119 |
134 | MP0000350_abnormal_cell_proliferation | 0.80718411 |
135 | MP0002168_other_aberrant_phenotype | 0.80690295 |
136 | MP0005166_decreased_susceptibility_to | 0.80635239 |
137 | MP0005266_abnormal_metabolism | 0.80407456 |
138 | MP0010630_abnormal_cardiac_muscle | 0.80205970 |
139 | MP0000604_amyloidosis | 0.79863529 |
140 | MP0002419_abnormal_innate_immunity | 0.79774270 |
141 | MP0005385_cardiovascular_system_phenoty | 0.79758139 |
142 | MP0001544_abnormal_cardiovascular_syste | 0.79758139 |
143 | MP0000598_abnormal_liver_morphology | 0.79675543 |
144 | MP0001614_abnormal_blood_vessel | 0.79400184 |
145 | MP0002139_abnormal_hepatobiliary_system | 0.78473434 |
146 | MP0001851_eye_inflammation | 0.78352088 |
147 | MP0003252_abnormal_bile_duct | 0.78186055 |
148 | MP0002118_abnormal_lipid_homeostasis | 0.77838971 |
149 | MP0000750_abnormal_muscle_regeneration | 0.77784574 |
150 | MP0004957_abnormal_blastocyst_morpholog | 0.77313517 |
151 | MP0003172_abnormal_lysosome_physiology | 0.75783180 |
152 | MP0002429_abnormal_blood_cell | 0.74351678 |
153 | MP0005257_abnormal_intraocular_pressure | 0.70592671 |
154 | MP0001697_abnormal_embryo_size | 0.70561097 |
155 | MP0003123_paternal_imprinting | 0.70367257 |
156 | MP0004087_abnormal_muscle_fiber | 0.70338476 |
157 | MP0009672_abnormal_birth_weight | 0.70022480 |
158 | MP0002452_abnormal_antigen_presenting | 0.69932656 |
159 | MP0002128_abnormal_blood_circulation | 0.69908570 |
160 | MP0003115_abnormal_respiratory_system | 0.69460678 |
161 | MP0002925_abnormal_cardiovascular_devel | 0.68801919 |
162 | MP0010094_abnormal_chromosome_stability | 0.68739359 |
163 | MP0002060_abnormal_skin_morphology | 0.68222729 |
164 | MP0002998_abnormal_bone_remodeling | 0.67452761 |
165 | MP0005193_abnormal_anterior_eye | 0.66195136 |
166 | MP0004197_abnormal_fetal_growth/weight/ | 0.65367234 |
167 | MP0005319_abnormal_enzyme/_coenzyme | 0.64898495 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nemaline bodies (HP:0003798) | 6.21848609 |
2 | Muscle fiber inclusion bodies (HP:0100299) | 6.17372886 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.90209314 |
4 | Exercise-induced muscle cramps (HP:0003710) | 4.44999773 |
5 | Stomatitis (HP:0010280) | 4.20003089 |
6 | Cerebral aneurysm (HP:0004944) | 4.13294711 |
7 | Abnormality of macrophages (HP:0004311) | 4.06249256 |
8 | Systemic lupus erythematosus (HP:0002725) | 4.04013389 |
9 | Exercise-induced myalgia (HP:0003738) | 3.89556549 |
10 | Retrobulbar optic neuritis (HP:0100654) | 3.76484178 |
11 | Optic neuritis (HP:0100653) | 3.76484178 |
12 | Myocardial infarction (HP:0001658) | 3.73900082 |
13 | Complement deficiency (HP:0004431) | 3.70594801 |
14 | Orchitis (HP:0100796) | 3.58724580 |
15 | Type 1 muscle fiber predominance (HP:0003803) | 3.40339562 |
16 | Subaortic stenosis (HP:0001682) | 3.39858940 |
17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.39858940 |
18 | Spontaneous hematomas (HP:0007420) | 3.33503253 |
19 | Hyporeflexia of lower limbs (HP:0002600) | 3.30502175 |
20 | Myositis (HP:0100614) | 3.25461171 |
21 | EMG: myopathic abnormalities (HP:0003458) | 3.22177508 |
22 | Aortic aneurysm (HP:0004942) | 3.20466077 |
23 | Glomerulonephritis (HP:0000099) | 3.20369745 |
24 | Recurrent skin infections (HP:0001581) | 3.16565098 |
25 | T lymphocytopenia (HP:0005403) | 3.10212719 |
26 | Abnormality of T cell number (HP:0011839) | 3.09290851 |
27 | Frequent falls (HP:0002359) | 3.06112193 |
28 | Ankle contracture (HP:0006466) | 3.05740491 |
29 | Abnormality of complement system (HP:0005339) | 2.98884902 |
30 | Protrusio acetabuli (HP:0003179) | 2.90131560 |
31 | Aortic dissection (HP:0002647) | 2.88527042 |
32 | Mitral valve prolapse (HP:0001634) | 2.87420189 |
33 | Keratoconjunctivitis sicca (HP:0001097) | 2.86644690 |
34 | Premature rupture of membranes (HP:0001788) | 2.83498260 |
35 | Arterial tortuosity (HP:0005116) | 2.77588316 |
36 | Distal arthrogryposis (HP:0005684) | 2.71683016 |
37 | Hyperglycinuria (HP:0003108) | 2.70713281 |
38 | Recurrent fungal infections (HP:0002841) | 2.70480497 |
39 | Chest pain (HP:0100749) | 2.67477719 |
40 | Mediastinal lymphadenopathy (HP:0100721) | 2.67191146 |
41 | Gastrointestinal infarctions (HP:0005244) | 2.62335245 |
42 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.60519762 |
43 | Osteolytic defects of the hand bones (HP:0009699) | 2.60519762 |
44 | Vascular tortuosity (HP:0004948) | 2.59690398 |
45 | Papillary thyroid carcinoma (HP:0002895) | 2.58337478 |
46 | Global brain atrophy (HP:0002283) | 2.56797756 |
47 | Hypoalphalipoproteinemia (HP:0003233) | 2.55928036 |
48 | Cortical dysplasia (HP:0002539) | 2.54209043 |
49 | Hematochezia (HP:0002573) | 2.53202713 |
50 | Male infertility (HP:0003251) | 2.52187921 |
51 | Meningitis (HP:0001287) | 2.51193026 |
52 | Amyloidosis (HP:0011034) | 2.50670161 |
53 | Keratoconjunctivitis (HP:0001096) | 2.49120413 |
54 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.47782295 |
55 | Arterial thrombosis (HP:0004420) | 2.46867608 |
56 | Nephritis (HP:0000123) | 2.46583620 |
57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45995695 |
58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45995695 |
59 | Increased connective tissue (HP:0009025) | 2.45288207 |
60 | Gingival bleeding (HP:0000225) | 2.44642507 |
61 | Rhabdomyolysis (HP:0003201) | 2.39722074 |
62 | Upper motor neuron abnormality (HP:0002127) | 2.37474537 |
63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37328509 |
64 | Urticaria (HP:0001025) | 2.36329621 |
65 | Aneurysm (HP:0002617) | 2.34288396 |
66 | Gingivitis (HP:0000230) | 2.34235242 |
67 | Nausea (HP:0002018) | 2.32164030 |
68 | Neck muscle weakness (HP:0000467) | 2.31896300 |
69 | Disinhibition (HP:0000734) | 2.30799712 |
70 | Osteomyelitis (HP:0002754) | 2.30346476 |
71 | Agnosia (HP:0010524) | 2.29568119 |
72 | Autoimmune thrombocytopenia (HP:0001973) | 2.28240682 |
73 | Areflexia of lower limbs (HP:0002522) | 2.27899355 |
74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27292951 |
75 | Shallow orbits (HP:0000586) | 2.26145762 |
76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24942824 |
77 | Hand muscle atrophy (HP:0009130) | 2.23410908 |
78 | Subacute progressive viral hepatitis (HP:0006572) | 2.20794738 |
79 | Fatigue (HP:0012378) | 2.19296000 |
80 | Striae distensae (HP:0001065) | 2.18996713 |
81 | Dilatation of the ascending aorta (HP:0005111) | 2.18531272 |
82 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.16159361 |
83 | Hypertriglyceridemia (HP:0002155) | 2.15239019 |
84 | Abnormality of the fingertips (HP:0001211) | 2.12974214 |
85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12659173 |
86 | Calf muscle hypertrophy (HP:0008981) | 2.12374501 |
87 | Abnormality of the endocardium (HP:0004306) | 2.11065890 |
88 | Bicuspid aortic valve (HP:0001647) | 2.10867295 |
89 | Lymphangioma (HP:0100764) | 2.08976416 |
90 | Vasculitis (HP:0002633) | 2.08698444 |
91 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08604038 |
92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08604038 |
93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08604038 |
94 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.07648556 |
95 | Hypochromic microcytic anemia (HP:0004840) | 2.07511024 |
96 | Camptodactyly of toe (HP:0001836) | 2.06860547 |
97 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06802010 |
98 | Abnormality of glycine metabolism (HP:0010895) | 2.06802010 |
99 | Amaurosis fugax (HP:0100576) | 2.05822123 |
100 | Multiple enchondromatosis (HP:0005701) | 2.04512540 |
101 | Deep venous thrombosis (HP:0002625) | 2.04083995 |
102 | Disproportionate tall stature (HP:0001519) | 2.03966746 |
103 | Encephalitis (HP:0002383) | 2.01897998 |
104 | Mutism (HP:0002300) | 2.00984440 |
105 | Acanthosis nigricans (HP:0000956) | 2.00663468 |
106 | Hemoptysis (HP:0002105) | 1.99841727 |
107 | Xanthomatosis (HP:0000991) | 1.99414500 |
108 | Oligomenorrhea (HP:0000876) | 1.98674029 |
109 | Increased cerebral lipofuscin (HP:0011813) | 1.98642771 |
110 | Recurrent bacterial skin infections (HP:0005406) | 1.98606650 |
111 | Leukocytosis (HP:0001974) | 1.98566034 |
112 | Soft skin (HP:0000977) | 1.98441040 |
113 | Eczematoid dermatitis (HP:0000976) | 1.97717917 |
114 | Myopathic facies (HP:0002058) | 1.97490016 |
115 | EMG: neuropathic changes (HP:0003445) | 1.96896038 |
116 | Enlarged penis (HP:0000040) | 1.96593137 |
117 | Inappropriate behavior (HP:0000719) | 1.96017247 |
118 | Viral hepatitis (HP:0006562) | 1.95710094 |
119 | Volvulus (HP:0002580) | 1.95295893 |
120 | Zonular cataract (HP:0010920) | 1.92289644 |
121 | Asymmetric septal hypertrophy (HP:0001670) | 1.91170089 |
122 | Rimmed vacuoles (HP:0003805) | 1.90937109 |
123 | Resting tremor (HP:0002322) | 1.90765144 |
124 | Recurrent abscess formation (HP:0002722) | 1.90446125 |
125 | Recurrent viral infections (HP:0004429) | 1.90404557 |
126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90120115 |
127 | Obstructive lung disease (HP:0006536) | 1.89050430 |
128 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89050430 |
129 | Distal lower limb muscle weakness (HP:0009053) | 1.87076792 |
130 | Amyotrophic lateral sclerosis (HP:0007354) | 1.87024865 |
131 | Stomach cancer (HP:0012126) | 1.86288633 |
132 | Abnormality of proline metabolism (HP:0010907) | 1.85236286 |
133 | Hydroxyprolinuria (HP:0003080) | 1.85236286 |
134 | Polyneuropathy (HP:0001271) | 1.85120915 |
135 | Peritonitis (HP:0002586) | 1.84782167 |
136 | Distal upper limb amyotrophy (HP:0007149) | 1.84294585 |
137 | Upper limb amyotrophy (HP:0009129) | 1.84294585 |
138 | Urethral obstruction (HP:0000796) | 1.84071044 |
139 | Spondylolisthesis (HP:0003302) | 1.83708679 |
140 | Myoglobinuria (HP:0002913) | 1.83600910 |
141 | Rectal prolapse (HP:0002035) | 1.81512274 |
142 | Genu recurvatum (HP:0002816) | 1.78709995 |
143 | Abnormality of the 4th metacarpal (HP:0010012) | 1.78119778 |
144 | Difficulty running (HP:0009046) | 1.77287797 |
145 | Pulmonary infiltrates (HP:0002113) | 1.75758239 |
146 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.72552768 |
147 | Short 4th metacarpal (HP:0010044) | 1.72552768 |
148 | Eosinophilia (HP:0001880) | 1.72273606 |
149 | Blue sclerae (HP:0000592) | 1.70982807 |
150 | Anorexia (HP:0002039) | 1.70091240 |
151 | Pulmonary embolism (HP:0002204) | 1.68919721 |
152 | Cervical subluxation (HP:0003308) | 1.68683415 |
153 | Hyperglycinemia (HP:0002154) | 1.67839602 |
154 | Azoospermia (HP:0000027) | 1.67518812 |
155 | Nuclear cataract (HP:0100018) | 1.67488504 |
156 | Facial diplegia (HP:0001349) | 1.67322810 |
157 | Ulnar deviation of the wrist (HP:0003049) | 1.67145498 |
158 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.66901280 |
159 | Conjunctival telangiectasia (HP:0000524) | 1.66781859 |
160 | Abnormal cartilage morphology (HP:0002763) | 1.66547114 |
161 | Ulnar bowing (HP:0003031) | 1.65304814 |
162 | High pitched voice (HP:0001620) | 1.65084849 |
163 | Epidermoid cyst (HP:0200040) | 1.64987186 |
164 | Tetraparesis (HP:0002273) | 1.64605815 |
165 | Episodic fever (HP:0001954) | 1.64241927 |
166 | Scapular winging (HP:0003691) | 1.63184177 |
167 | Increased variability in muscle fiber diameter (HP:0003557) | 1.62322472 |
168 | Polycythemia (HP:0001901) | 1.61678219 |
169 | Progressive inability to walk (HP:0002505) | 1.60563641 |
170 | Cellulitis (HP:0100658) | 1.60541272 |
171 | Hypolipoproteinemia (HP:0010981) | 1.58868485 |
172 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.58663671 |
173 | Hemorrhage of the eye (HP:0011885) | 1.57990453 |
174 | Peripheral demyelination (HP:0011096) | 1.57976713 |
175 | Abnormality of the lumbar spine (HP:0100712) | 1.57734306 |
176 | Wrist flexion contracture (HP:0001239) | 1.56425501 |
177 | Achilles tendon contracture (HP:0001771) | 1.56276216 |
178 | Abnormality of the Achilles tendon (HP:0005109) | 1.54753858 |
179 | Subcapsular cataract (HP:0000523) | 1.54469897 |
180 | Skin nodule (HP:0200036) | 1.54392433 |
181 | Muscle fiber splitting (HP:0003555) | 1.53879111 |
182 | Coarse hair (HP:0002208) | 1.53359141 |
183 | Metaphyseal cupping (HP:0003021) | 1.53242998 |
184 | Axonal loss (HP:0003447) | 1.52778603 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 4.16632941 |
2 | TRIB3 | 3.84854921 |
3 | CAMK1D | 3.68178350 |
4 | LATS1 | 3.50510212 |
5 | CDK12 | 3.33347401 |
6 | RIPK4 | 3.05099884 |
7 | TGFBR2 | 2.71589528 |
8 | IRAK2 | 2.62848535 |
9 | LATS2 | 2.57662670 |
10 | PIK3CG | 2.45878397 |
11 | CAMK1G | 2.28801153 |
12 | PKN2 | 2.20611163 |
13 | STK3 | 2.11358702 |
14 | IRAK4 | 2.07259818 |
15 | STK38L | 2.05109759 |
16 | YES1 | 2.01746514 |
17 | MAP3K13 | 1.99654642 |
18 | STK10 | 1.88693769 |
19 | TTN | 1.74907140 |
20 | EEF2K | 1.70150183 |
21 | MAP3K14 | 1.70143264 |
22 | ERN1 | 1.69023822 |
23 | KSR1 | 1.68027543 |
24 | NEK2 | 1.67944076 |
25 | PRPF4B | 1.65988152 |
26 | PDGFRA | 1.64170193 |
27 | CSF1R | 1.63019650 |
28 | RIPK1 | 1.61581303 |
29 | TIE1 | 1.56897396 |
30 | CDK9 | 1.50600624 |
31 | ERBB3 | 1.49808137 |
32 | BMX | 1.45377601 |
33 | MAP3K10 | 1.43706909 |
34 | MAP3K5 | 1.43510322 |
35 | SIK1 | 1.42949525 |
36 | STK24 | 1.40882053 |
37 | NEK9 | 1.39222663 |
38 | CDK6 | 1.38779851 |
39 | PINK1 | 1.36144715 |
40 | PHKG2 | 1.34556391 |
41 | PHKG1 | 1.34556391 |
42 | FES | 1.25907882 |
43 | FGFR3 | 1.25816949 |
44 | TYK2 | 1.23494162 |
45 | MAP2K4 | 1.22331965 |
46 | PTK6 | 1.22249539 |
47 | MAP3K2 | 1.21439331 |
48 | SGK3 | 1.21335338 |
49 | CDK4 | 1.20779739 |
50 | RAF1 | 1.17412960 |
51 | TTK | 1.17146914 |
52 | MTOR | 1.15123757 |
53 | PDK4 | 1.14614595 |
54 | PDK3 | 1.14614595 |
55 | ACVR1B | 1.13952574 |
56 | BRD4 | 1.11457273 |
57 | PDGFRB | 1.09695926 |
58 | MARK3 | 1.09550716 |
59 | SGK2 | 1.08560401 |
60 | MOS | 1.08533652 |
61 | PAK4 | 1.07944671 |
62 | CDC7 | 1.05650127 |
63 | PDK2 | 1.05378150 |
64 | FGFR4 | 1.04226847 |
65 | SIK3 | 0.98983832 |
66 | DMPK | 0.98832280 |
67 | PRKAA2 | 0.96190934 |
68 | CSK | 0.92879466 |
69 | SYK | 0.90413598 |
70 | MAP4K1 | 0.87721524 |
71 | CAMKK2 | 0.87421809 |
72 | PAK2 | 0.86072897 |
73 | NUAK1 | 0.84209783 |
74 | PDK1 | 0.84158041 |
75 | JAK1 | 0.83773985 |
76 | TNIK | 0.83384422 |
77 | NEK6 | 0.82255019 |
78 | MAP2K3 | 0.81691989 |
79 | NME1 | 0.81281856 |
80 | TRPM7 | 0.80909716 |
81 | RPS6KA4 | 0.80682738 |
82 | MST4 | 0.80034560 |
83 | SCYL2 | 0.79452433 |
84 | NLK | 0.79314489 |
85 | JAK3 | 0.79161028 |
86 | TYRO3 | 0.77347314 |
87 | BLK | 0.77032900 |
88 | FGR | 0.74386665 |
89 | MAP3K1 | 0.74142452 |
90 | MAP3K6 | 0.73750821 |
91 | IRAK1 | 0.73543833 |
92 | MAP3K8 | 0.72787944 |
93 | MAP3K9 | 0.72286290 |
94 | LYN | 0.71545775 |
95 | RPS6KB1 | 0.71116392 |
96 | TAOK1 | 0.70756703 |
97 | TAOK3 | 0.70694544 |
98 | PRKAA1 | 0.70466334 |
99 | IKBKE | 0.70330908 |
100 | TNK2 | 0.69722768 |
101 | JAK2 | 0.68999106 |
102 | CDK7 | 0.64577315 |
103 | MELK | 0.64492222 |
104 | DYRK3 | 0.61687475 |
105 | BTK | 0.61421389 |
106 | STK4 | 0.58919243 |
107 | MET | 0.58892762 |
108 | CAMK4 | 0.58846226 |
109 | FLT3 | 0.58713474 |
110 | ZAP70 | 0.58397561 |
111 | RET | 0.57683942 |
112 | MAPK7 | 0.57563876 |
113 | LRRK2 | 0.57293923 |
114 | GRK6 | 0.57122053 |
115 | ABL1 | 0.56926843 |
116 | MAP3K3 | 0.55816547 |
117 | ERBB4 | 0.55765804 |
118 | BRSK2 | 0.55552643 |
119 | STK38 | 0.55107398 |
120 | PNCK | 0.54943425 |
121 | CHEK2 | 0.53195303 |
122 | EIF2AK3 | 0.53039286 |
123 | KSR2 | 0.51571353 |
124 | KIT | 0.51200873 |
125 | PTK2B | 0.51007623 |
126 | PRKG1 | 0.49952110 |
127 | TBK1 | 0.49075305 |
128 | BCKDK | 0.49014972 |
129 | STK11 | 0.48818351 |
130 | ABL2 | 0.48330122 |
131 | HCK | 0.47758591 |
132 | EPHA3 | 0.44960473 |
133 | WNK1 | 0.44378048 |
134 | DDR2 | 0.43944252 |
135 | PLK1 | 0.42720050 |
136 | MAP3K7 | 0.42491484 |
137 | MAPK12 | 0.42207436 |
138 | TEC | 0.41969451 |
139 | ICK | 0.41830746 |
140 | FGFR1 | 0.41732917 |
141 | PRKCQ | 0.41457734 |
142 | IGF1R | 0.41223849 |
143 | PTK2 | 0.41214526 |
144 | MAPK11 | 0.40579326 |
145 | EGFR | 0.40153526 |
146 | CDK8 | 0.39340653 |
147 | AURKB | 0.39061878 |
148 | CHUK | 0.38719294 |
149 | MATK | 0.37863199 |
150 | MARK2 | 0.37789264 |
151 | PRKD1 | 0.36900498 |
152 | LCK | 0.36772415 |
153 | PIM1 | 0.36386935 |
154 | FGFR2 | 0.34979366 |
155 | SGK1 | 0.33515533 |
156 | PRKD2 | 0.33515289 |
157 | PDPK1 | 0.33419368 |
158 | EPHB1 | 0.32834957 |
159 | MAPK10 | 0.31675555 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81982577 |
2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.65598411 |
3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.00100575 |
4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.97510032 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85051824 |
6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.84415787 |
7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.83826542 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80953336 |
9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72990488 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66966730 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58691064 |
12 | Phagosome_Homo sapiens_hsa04145 | 1.55667960 |
13 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54852406 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.54362674 |
15 | Lysine degradation_Homo sapiens_hsa00310 | 1.54228346 |
16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.45487306 |
17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.41749374 |
18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38488315 |
19 | Adherens junction_Homo sapiens_hsa04520 | 1.37090687 |
20 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.35281546 |
21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34533006 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.32652473 |
23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30043526 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.27742077 |
25 | Insulin resistance_Homo sapiens_hsa04931 | 1.27438347 |
26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26984931 |
27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.26757731 |
28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22552883 |
29 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.21758397 |
30 | Lysosome_Homo sapiens_hsa04142 | 1.21352864 |
31 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.21035777 |
32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.18255067 |
33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14144843 |
34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.12066699 |
35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11732885 |
36 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10128457 |
37 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.09792746 |
38 | Cell cycle_Homo sapiens_hsa04110 | 1.09176690 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06904629 |
40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06521204 |
41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05990473 |
42 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04391281 |
43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03309622 |
44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02102138 |
45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01927732 |
46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.00963176 |
47 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.00938530 |
48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00676594 |
49 | Allograft rejection_Homo sapiens_hsa05330 | 0.98963173 |
50 | Focal adhesion_Homo sapiens_hsa04510 | 0.98819926 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98170087 |
52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96298185 |
53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95695389 |
54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95395362 |
55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95008033 |
56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93468968 |
57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.92936161 |
58 | Pertussis_Homo sapiens_hsa05133 | 0.92640358 |
59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92484647 |
60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92369721 |
61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91490313 |
62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90466767 |
63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90334877 |
64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89411588 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87105631 |
66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86994274 |
67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85790468 |
68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84085589 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83785212 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.82894845 |
71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81928937 |
72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80856929 |
73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80702353 |
74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79899220 |
75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79761446 |
76 | Glioma_Homo sapiens_hsa05214 | 0.78985327 |
77 | Apoptosis_Homo sapiens_hsa04210 | 0.78448653 |
78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78046148 |
79 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.77058346 |
80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77047898 |
81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76448007 |
82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76419664 |
83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76178538 |
84 | Amoebiasis_Homo sapiens_hsa05146 | 0.75844563 |
85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75443645 |
86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.74764637 |
87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74631447 |
88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74389469 |
89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73882261 |
90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72388605 |
91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71817585 |
92 | Tuberculosis_Homo sapiens_hsa05152 | 0.71432888 |
93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71086094 |
94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69668638 |
95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69481897 |
96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69065270 |
97 | Salmonella infection_Homo sapiens_hsa05132 | 0.68729652 |
98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67596409 |
99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67233326 |
100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66411226 |
101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66196789 |
102 | Hepatitis B_Homo sapiens_hsa05161 | 0.66095340 |
103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66041831 |
104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65509561 |
105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64928504 |
106 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64267692 |
107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63017872 |
108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62970264 |
109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62557198 |
110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61622721 |
111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61430948 |
112 | Shigellosis_Homo sapiens_hsa05131 | 0.60801918 |
113 | Legionellosis_Homo sapiens_hsa05134 | 0.59857848 |
114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59001463 |
115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58226258 |
116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57886571 |
117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55762302 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54946089 |
119 | Malaria_Homo sapiens_hsa05144 | 0.53981920 |
120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.53854130 |
121 | Prostate cancer_Homo sapiens_hsa05215 | 0.53618330 |
122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53073084 |
123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52885430 |
124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52379820 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.51374856 |
126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51174476 |
127 | RNA transport_Homo sapiens_hsa03013 | 0.51134423 |
128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50660162 |
129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50618698 |
130 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50537401 |
131 | Platelet activation_Homo sapiens_hsa04611 | 0.50442368 |
132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50256311 |
133 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50191332 |
134 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49838094 |
135 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49363790 |
136 | Measles_Homo sapiens_hsa05162 | 0.48776459 |
137 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47816809 |
138 | ABC transporters_Homo sapiens_hsa02010 | 0.47632266 |
139 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47194894 |
140 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46075260 |
141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45921740 |
142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.43484240 |
143 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42739885 |